Valuation · EV/EBITDA model
Is Clorox (CLX) stock undervalued?
On November 4, 2026, with the shares at $93.80, a quick EV/EBITDA model by Brief Equity valued Clorox at about $162 a share for fiscal 2029. Clorox looks undervalued on that model if cost savings bring its EBIT margin back to the roughly 18% it used to earn, while the company keeps paying its dividend.
By The Brief Equity Team · Model dated · Published

The model's assumptions for Clorox
Clorox's fiscal year ends on June 30, and the last year it has reported is fiscal 2026. The model runs three years, to fiscal 2029. Every row below is the model's own except the analyst consensus revenue.
| Fiscal 2027 | Fiscal 2028 | Fiscal 2029 | |
|---|---|---|---|
| Net sales, model | 7.63 | 7.89 | 8.17 |
| Revenue growth, model | 13.5% | 3.5% | 3.5% |
| EBITDA, model | 1.33 | 1.54 | 1.76 |
| EBITDA margin, model | 17.5% | 19.5% | 21.5% |
| Net sales, analyst consensus | 7.63 | 7.81 | 8.01 |
Why Clorox looks undervalued
More than 80% of Clorox's sales come from brands that rank first or second by market share in their categories, but the company has had a difficult few years. Clorox was hit by a cyberattack in August 2023. In the fourth quarter of fiscal 2025, retailers built up inventory ahead of its switch to a new ERP system, and they drew it down in fiscal 2026, which the company says cost about 7.5 points of sales growth and about 90 cents of earnings per share in fiscal 2026.
Clorox's gross margin fell from 45.2% in fiscal 2025 to 42.3% in fiscal 2026, and its adjusted EBIT fell from $1,316 million to $1,030 million.
Clorox bought GOJO, the maker of Purell, on April 1, 2026 for approximately $2.15 billion, mostly with borrowed money. The acquisition accounts for about 9.5 points of the 13% to 14% net sales growth Clorox expects for fiscal 2027, and its chief financial officer put organic growth excluding the ERP effect at flat to plus 1% for the year. S&P Global Ratings lowered Clorox's long-term credit rating to BBB from BBB+ in February 2026, the company says cash flow goes first to repaying debt, and it bought back no shares in the quarter ended September 30, 2026.
The model lifts Clorox's EBITDA margin from 17.5% in fiscal 2027 to 21.5% in fiscal 2029, which puts its EBIT margin at 17.80% in that year. Analyst consensus has the EBITDA margin at 18.4% for fiscal 2029. The model's revenue follows the company's outlook in fiscal 2027 and then grows 3.5% a year, against analyst consensus of 2.3% and 2.6%. With an exit multiple of 12.9 times EBITDA, close to the 12.92 times at which the shares traded on November 3, 2026, the model values Clorox at about $162 a share for fiscal 2029, about 73% above the share price.
“job one is getting back to historical EBIT margin, right, which were about 18%.”
Luc Bellet, Chief Financial Officer, Clorox first-quarter fiscal 2027 earnings call, November 2, 2026
Clorox's margin recovery depends on cost savings outpacing inflation. The first quarter of fiscal 2027 brought one of the company's highest quarters of cost savings on record, and its chief financial officer said most of the margin recovery comes from cost savings and productivity. Clorox now expects about $240 million of input cost inflation in fiscal 2027, about 2.5 times its historical annual average, and it lowered its fiscal 2027 gross margin outlook to about 41.5%. Fabian Garcia, president of Unilever Personal Care, becomes Clorox's chief executive on January 5, 2027.
What has to be true, and what would break it
Clorox looks undervalued on this model if cost savings outpace inflation and its margin returns to where it used to be.
What has to be true
- Clorox's EBITDA margin rises from 17.5% in fiscal 2027 to 21.5% in fiscal 2029, above analyst consensus of 18.4% for fiscal 2029.
- Clorox's cost savings and productivity outpace input cost inflation, which the company expects to be about $240 million in fiscal 2027.
- Clorox's revenue grows 3.5% a year in fiscal 2028 and fiscal 2029, after the 13.5% the model takes for fiscal 2027.
- The market pays about 12.9 times Clorox's EBITDA at the end of fiscal 2029.
What would break it
- Input cost inflation stays near Clorox's fiscal 2027 level, about 2.5 times its historical annual average, and holds gross margin at or below the fiscal 2027 outlook of about 41.5%.
- Clorox's organic growth excluding the ERP effect stays near the flat to plus 1% it expects for fiscal 2027.
- Clorox's new chief executive, who starts on January 5, 2027, resets the company's plans or its outlook.
- The market pays less than 12.9 times Clorox's EBITDA at the end of fiscal 2029.
The parts of Clorox's business
Clorox reports its net sales in four segments. In fiscal 2026 Health and Wellness, which includes Purell from April 1, 2026, was the largest, and total net sales fell 5% from fiscal 2025.
| Share of revenue | |
|---|---|
| Health and Wellness | 40.1% |
| Household | 26.6% |
| Lifestyle | 16.7% |
| International | 16.6% |
Clorox beside its peers
Clorox is compared here with six US-listed companies, chosen to cover its cleaning, cat litter, trash bag, professional hygiene and dressings businesses.
- PG: Home cleaning
- CL: Home care cleaners
- CHD: Cat litter
- REYN: Trash bags and wrap
- ECL: Professional cleaning and hygiene
- MKC: Dressings and condiments

How the estimate moves with its assumptions
The two Clorox cards below test the estimate. The sensitivity grids change two assumptions at a time, and the Monte Carlo card reruns the model many times with growth, margin and the exit multiple drawn at random.


Questions about Clorox
These questions about Clorox (CLX) are answered from the documents listed under Sources.
- Which brands does Clorox own?
- As of November 2026, Clorox's brands include Brita, Burt's Bees, Clorox, Fresh Step, Glad, Hidden Valley, Kingsford, Liquid-Plumr, Pine-Sol and Purell, along with international brands such as Chux, Clorinda and Poett.
- Who is Clorox's largest customer?
- Walmart accounted for 26% of Clorox's net sales in fiscal 2026, which ended June 30, 2026. Clorox's five largest customers accounted for about half of its net sales.
- How much debt does Clorox have?
- As of September 30, 2026, Clorox had $1,175 million of notes and loans payable and $3,982 million of long-term debt, against $184 million of cash.
- What earnings does Clorox expect for fiscal 2027?
- As of November 2, 2026, Clorox expected adjusted EPS of $5.70 to $6.00 for fiscal 2027, closer to the low end of that range, and diluted EPS of $5.41 to $5.71.
- What dividend does Clorox pay?
- On July 31, 2026, Clorox raised its quarterly dividend by 1%, from $1.24 to $1.25 a share. It paid $602 million of dividends in fiscal 2026.
- What happened to the Glad joint venture with Procter & Gamble?
- Clorox paid $476 million in cash on March 2, 2026 for Procter & Gamble's 20% interest in the Glad business. Clorox now runs Glad on its own, without P&G's research and development support.
Sources
The quotations and facts about Clorox (CLX) on this page rest on the documents below.
- Clorox annual report on Form 10-K for fiscal 2026, August 7, 2026
- Clorox financial statements and management's discussion for fiscal 2026, Exhibit 99.1 to the Form 10-K, August 7, 2026
- Clorox quarterly report on Form 10-Q for the first quarter of fiscal 2027, November 2, 2026
- Clorox first-quarter fiscal 2027 results release, November 2, 2026
- Clorox first-quarter fiscal 2027 earnings call, November 2, 2026
- Enterprise value to EBITDA for Clorox at the November 3, 2026 close, November 4, 2026
- Clorox appoints Fabian Garcia as chief executive, October 29, 2026
About this page
Brief Equity and its team hold no position in Clorox (CLX) as of November 4, 2026.
This page is research, not investment advice. It describes one model and the assumptions behind it, and market data is delayed. Read how these models are built and our editorial policy.
Related guides: How to read a 10-K (SEC filing), Where to read earnings transcripts and filings in one place, How to value a stock yourself (without Excel).